University of Iceland
Reykjavik, 102, Iceland
NCT Number: NCT07465354
The aim of the study is to examine the effectiveness of OCD treatment delivered in a group format for adolescents during a two week intensive summer treatment program.
Trial opening soon.
Get Notified12 year–18 year
All sexes
Interventional
Not applicable
Reykjavik, 102, Iceland
The present study evaluates the effectiveness of the Icelandic adaptation of the Pediatric OCD Summer Program, originally developed by the British Columbia Children's Hospital in Vancouver, Canada. Specifically, it investigates the efficacy of this intensive intervention for Icelandic adolescents with OCD and their parents. The study also examines how executive functioning and emotion regulation may change over the course of treatment and influence outcomes, particularly among adolescents with co-occurring neurodevelopmental conditions such as ADHD and/or autism. The program will be implemented annually as an open clinical trial to accumulate a larger dataset and address these research questions comprehensively.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This cognitive-behavioral exposure / response prevention program is delivered intensively over two consecutive weeks, consisting of daily 2.5-hour sessions across 10 days. Each group includes 6-8 adolescents, with every participant paired with an individual therapist for each session, though therapists rotate daily. At the outset, adolescents receive workbooks and psychoeducation on the nature of obsessive thoughts and compulsive behaviors, along with strategies to manage symptoms and reduce impairment. The primary focus of the program is individualized exposure exercises conducted with a therapist during each session. Designed for adolescents aged 12-18, the program also includes parent sessions, in which parents learn to manage anxiety-driven behaviors at home and reduce family accommodation.
Time frame: Baseline, 1 week after treatment, 6 month follow-up, 12 month follow-up
A questionnaire designed to assess executive functioning in children and adolescents aged 5 to 18 years (Gioia et al., 2000). The questionnaire consists of 86 items with three response options: never = 1, sometimes = 2, and often = 3. A higher score on the BRIEF indicates greater executive functioning difficulties. The first 72 items are divided into eight clinical subscales that measure different aspects of executive function. These clinical subscales fall under two broader indices: the Behavioral Regulation Index (BRI) and the Metacognition Index (MI), which together form a Global Executive Composite (GEQ) score. The psychometric properties of the Icelandic version have proven to be acceptable.
Time frame: Baseline, 1 week after treatment, 6 month follow-up, 12 month follow-up
This is a semi-structured interview (Scahill et al., 1997) intended to assess the symptoms and severity of obsessive compulsive disorder in children and adolescents aged 6-17 years. The scores range from 0-40, a higher score indicating more OCD related impairment with a clinical cut-off score of 15. The interview is conducted either with both the child and parent present or, in some cases, separately. The interview method depends, among other things, on the child´s age and developmental level. This interview is widely used, both for clinical purposes and in research, and has been translated into many languages. Today, it is considered the gold standard for assessing the severity of OCD symptoms and treatment response and is the most commonly and widely accepted tool for such evaluations (Mataix-Cols et al, 2016; Skarphedinsson et al, 2017). The interview has demonstrated strong psychometric properties (Cook et al., 2015; Højgaard et al., 2017).
Time frame: Baseline, 1 week after treatment, 6 month follow-up, 12 month follow-up
This is a 55-item questionnaire that assesses functional impairment due to OCD in the child's most important environments (home, school, and social situations) (Piacentini et al, 2007). Each question is rated on a Likert scale from 0-3 and a higher score indicates more OCD related impairment. The adolescents will complete the child/adolescent form and parents will complete the parent form.
Time frame: Baseline, 1 week after treatment, 6 month follow-up, 12 month follow-up
This is a commonly used questionnaire to screen for anxiety and depressive disorders and to assess changes following an intervention. The RCADS is a 47-item questionnaire designed for parents and children (ages 8-17) and includes the following scales: Generalized Anxiety Disorder, Separation Anxiety Disorder, Social Anxiety Disorder, Panic Disorder, Obsessive-Compulsive Disorder, and Depressive Symptoms. Items are rated on a four-point scale and higher scores indicate more difficulties: 0 = never, 1 = sometimes, 2 = often, 3 = always. The Icelandic version has acceptable psychometric properties in both general and clinical populations.
Time frame: Baseline, 1 week after treatment, 6 month follow-up, 12 month follow-up
This is a 19-item scale developed to assess the extent to which the family attempts to accommodate the child´s symptoms to reduce distress. The scale is completed by parents and includes items such as how much the family tries to reassure the child, alter plans and activities, or help the child to avoid objects, places, or situations that cause distress. Scores range from 0-48 and higher scores indicate more family accommodation. The scale has acceptable psychometric properties, including internal consistency of 0.90 and high correlation with the standardized Family Accommodation Interview (Pinto et al., 2013).
Contact information is provided by the study sponsor or research team.
University of Iceland
Other
Intensive OCD Summer Treatment Program for 12-18-year-old Adolescents in Iceland
Acronym: OCDtreatment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07419009
Anxiety Disorders, Mental Disorders
View Trial DetailsNCT05422469
Anxiety Disorders, Mental Disorders
Providence, Rhode Island, United States
View Trial DetailsNCT07081438
Anxiety Disorders, Mental Disorders
View Trial DetailsNCT06360991
Anxiety Disorders, Mental Disorders
Beijing, China
View Trial Details